These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 3932748)
1. [Long-term therapy of familial hypercholesterolemia in young patients with colestipol: availability of minerals and vitamins]. Schlierf G; Vogel G; Kohlmeier M; Vuilleumier JP; Hüppe R; Schmidt-Gayk H Klin Wochenschr; 1985 Sep; 63(17):802-6. PubMed ID: 3932748 [TBL] [Abstract][Full Text] [Related]
2. Fat-soluble vitamin concentrations in hypercholesterolemic children treated with colestipol. Schwarz KB; Goldstein PD; Witztum JL; Schonfeld G Pediatrics; 1980 Feb; 65(2):243-50. PubMed ID: 7354970 [TBL] [Abstract][Full Text] [Related]
3. "Low dose" colestipol in children, adolescents and young adults with familial hypercholesterolemia. Schlierf G; Mrozik K; Heuck CC; Middelhoff G; Oster P; Riesen W; Schellenberg B Atherosclerosis; 1982 Jan; 41(1):133-8. PubMed ID: 7073790 [TBL] [Abstract][Full Text] [Related]
4. Colestipol and probucol: treatment of primary and familial hypercholesterolemia and amelioration of atherosclerosis. Glueck CJ Ann Intern Med; 1982 Apr; 96(4):475-82. PubMed ID: 7039445 [TBL] [Abstract][Full Text] [Related]
5. Diet, drugs, and plasma exchange in the treatment of hyperlipidemia in childhood. Mancini M; Postiglione A; Farinaro E; Montefusco S Prev Med; 1983 Nov; 12(6):848-53. PubMed ID: 6676732 [No Abstract] [Full Text] [Related]
6. Low dose colestipol in adolescents with familial hypercholesterolaemia. Tonstad S; Sivertsen M; Aksnes L; Ose L Arch Dis Child; 1996 Feb; 74(2):157-60. PubMed ID: 8660081 [TBL] [Abstract][Full Text] [Related]
7. Familial type II hyperlipoproteinemia with coronary heart disease: effect of diet-colestipol-nicotinic acid treatment. Kuo PT; Kostis JB; Moreyra AE; Hayes JA Chest; 1981 Mar; 79(3):286-91. PubMed ID: 7471860 [TBL] [Abstract][Full Text] [Related]
8. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride. Witztum JL; Simmons D; Steinberg D; Beltz WF; Weinreb R; Young SG; Lester P; Kelly N; Juliano J Circulation; 1989 Jan; 79(1):16-28. PubMed ID: 2642754 [TBL] [Abstract][Full Text] [Related]
9. [The long-term effects of colestipol hydrochloride on serum and lipoprotein lipids in patients with heterozygous familial hypercholesterolemia (author's transl)]. Wakasugi T; Sakai T; Watanabe A; Tatami R; Ueda K; Ueda R; Kametani T; Haba T; Koizumi J; Miyamoto S; Mabuchi H; Takeda R; Sakai Y; Yoshimura A; Takegoshi T; Ohta M; Ono S; Ohka T; Takeshita H Nihon Ronen Igakkai Zasshi; 1981 Nov; 18(6):432-40. PubMed ID: 7339082 [No Abstract] [Full Text] [Related]
10. Plasma 25-hydroxy-vitamin D in familial hypercholesterolemic children receiving colestipol resin. Tsang RC; Roginsky MS; Mellies MJ; Glueck CJ Pediatr Res; 1978 Oct; 12(10):980-2. PubMed ID: 724301 [No Abstract] [Full Text] [Related]
11. Primary hypercholesterolemia: effect of treatment on serum lipids, lipoprotein fractions, cholesterol absorption, sterol balance, and platelet aggregation. Briones ER; Steiger D; Palumbo PJ; Kottke BA Mayo Clin Proc; 1984 Apr; 59(4):251-7. PubMed ID: 6708603 [TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia. Vecchio TJ; Linden CV; O'Connell MJ; Heilman J Arch Intern Med; 1982 Apr; 142(4):721-3. PubMed ID: 7073415 [TBL] [Abstract][Full Text] [Related]
13. Colestipol in familial type II hyperlipoproteinemia: a three-year trial. Harvengt C; Desager JP Clin Pharmacol Ther; 1976 Sep; 20(3):310-4. PubMed ID: 182429 [TBL] [Abstract][Full Text] [Related]
14. [A comparative study of colestipol and colestyramine in children and adolescents with familial hypercholesterolaemia (author's transl)]. Mordasini R; Twelsick F; Oster P; Schellenberg B; Raetzer H; Heuck CC; Schlierf G Monatsschr Kinderheilkd (1902); 1978 Jul; 126(7):436-40. PubMed ID: 672910 [TBL] [Abstract][Full Text] [Related]
15. Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia. Kuo PT; Hayase K; Kostis JB; Moreyra AE Circulation; 1979 Feb; 59(2):199-211. PubMed ID: 215338 [TBL] [Abstract][Full Text] [Related]
16. Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease. Kuo PT; Wilson AC; Kostis JB; Moreyra AE Am J Cardiol; 1986 Jun; 57(16):43H-48H. PubMed ID: 3524177 [TBL] [Abstract][Full Text] [Related]
17. [Results of 6 months, therapy of familial hypercholesterolemia (hyperlipoproteinemia type II) with colestipol]. Kuŝić M; Gavrilović M; Mihajloviĉ M; Boŝković B Srp Arh Celok Lek; 1980 Sep; 108(9):875-81. PubMed ID: 7302695 [No Abstract] [Full Text] [Related]
18. [Long term treatment of familial hypercholesterolemia with Colestipol, a new anionic exchange resin (author's transl)]. Briani G; Fellin R; Balestrieri P; Baggio G; Baiocchi MR; Crepaldi G G Ital Cardiol; 1975; 5(3):390-404. PubMed ID: 1149965 [TBL] [Abstract][Full Text] [Related]
19. Extracranial carotid arterial disease in patients with familial hypercholesterolemia and coronary artery disease treated with colestipol and nicotinic acid. Kuo PT; Toole JF; Schaaf JA; Jones A; Wilson AC; Kostis JB; Moreyra AE Stroke; 1987; 18(4):716-21. PubMed ID: 3299882 [TBL] [Abstract][Full Text] [Related]
20. Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholesterolemia. Illingworth DR Ann Intern Med; 1984 Nov; 101(5):598-604. PubMed ID: 6567462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]